226 related articles for article (PubMed ID: 9634007)
1. O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
Dolan ME; Roy SK; Garbiras BJ; Helft P; Paras P; Chae MY; Moschel RC; Pegg AE
Biochem Pharmacol; 1998 May; 55(10):1701-9. PubMed ID: 9634007
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
Ewesuedo RB; Wilson LR; Friedman HS; Moschel RC; Dolan ME
Cancer Chemother Pharmacol; 2001; 47(1):63-9. PubMed ID: 11221964
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.
Zhu R; Baumann RP; Penketh PG; Shyam K; Sartorelli AC
J Med Chem; 2013 Feb; 56(3):1355-9. PubMed ID: 23311288
[TBL] [Abstract][Full Text] [Related]
4. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells.
Hamdan MA; Guzman RC; Yang J; Beattie C; Mascharack P; Nandi S
Carcinogenesis; 1992 Oct; 13(10):1743-9. PubMed ID: 1423833
[TBL] [Abstract][Full Text] [Related]
5. Effect of DNA on the inactivation of O6-alkylguanine-DNA alkyltransferase by 9-substituted O6-benzylguanine derivatives.
Pegg AE; Chung L; Moschel RC
Biochem Pharmacol; 1997 May; 53(10):1559-64. PubMed ID: 9260884
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine.
Javanmard S; Loktionova NA; Fang Q; Pauly GT; Pegg AE; Moschel RC
J Med Chem; 2007 Oct; 50(21):5193-201. PubMed ID: 17880193
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human O6-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by O6-benzylguanine.
Xu-Welliver M; Kanugula S; Pegg AE
Cancer Res; 1998 May; 58(9):1936-45. PubMed ID: 9581836
[TBL] [Abstract][Full Text] [Related]
8. 8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferase.
Chae MY; Swenn K; Kanugula S; Dolan ME; Pegg AE; Moschel RC
J Med Chem; 1995 Jan; 38(2):359-65. PubMed ID: 7830279
[TBL] [Abstract][Full Text] [Related]
9. Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
Pegg AE; Swenn K; Chae MY; Dolan ME; Moschel RC
Biochem Pharmacol; 1995 Oct; 50(8):1141-8. PubMed ID: 7488227
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the conserved residue tyrosine-158 to histidine renders human O6-alkylguanine-DNA alkyltransferase insensitive to the inhibitor O6-benzylguanine.
Xu-Welliver M; Leitão J; Kanugula S; Pegg AE
Cancer Res; 1999 Apr; 59(7):1514-9. PubMed ID: 10197622
[TBL] [Abstract][Full Text] [Related]
11. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
[TBL] [Abstract][Full Text] [Related]
12. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
[TBL] [Abstract][Full Text] [Related]
13. Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
Cai Y; Wu MH; Xu-Welliver M; Pegg AE; Ludeman SM; Dolan ME
Cancer Res; 2000 Oct; 60(19):5464-9. PubMed ID: 11034089
[TBL] [Abstract][Full Text] [Related]
14. Conserved residue lysine165 is essential for the ability of O6-alkylguanine-DNA alkyltransferase to react with O6-benzylguanine.
Xu-Welliver M; Kanugula S; Loktionova NA; Crone TM; Pegg AE
Biochem J; 2000 Apr; 347(Pt 2):527-34. PubMed ID: 10749683
[TBL] [Abstract][Full Text] [Related]
15. Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.
Crone TM; Goodtzova K; Edara S; Pegg AE
Cancer Res; 1994 Dec; 54(23):6221-7. PubMed ID: 7954470
[TBL] [Abstract][Full Text] [Related]
16. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.
Loktionova NA; Pegg AE
Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405
[TBL] [Abstract][Full Text] [Related]
17. Role of codon 160 in the sensitivity of human O6-alkylguanine-DNA alkyltransferase to O6-benzylguanine.
Xu-Welliver M; Leitão J; Kanugula S; Meehan WJ; Pegg AE
Biochem Pharmacol; 1999 Oct; 58(8):1279-85. PubMed ID: 10487529
[TBL] [Abstract][Full Text] [Related]
18. Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferase.
Moschel RC; McDougall MG; Dolan ME; Stine L; Pegg AE
J Med Chem; 1992 Nov; 35(23):4486-91. PubMed ID: 1447749
[TBL] [Abstract][Full Text] [Related]
19. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
Long L; Berg SL; Roy SK; McCully CL; Song-Yoo HW; Moschel RC; Balis FM; Dolan ME
Clin Cancer Res; 2000 Sep; 6(9):3662-9. PubMed ID: 10999759
[TBL] [Abstract][Full Text] [Related]
20. 2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase.
Nelson ME; Loktionova NA; Pegg AE; Moschel RC
J Med Chem; 2004 Jul; 47(15):3887-91. PubMed ID: 15239666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
